BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26519074)

  • 1. Biofilms and Antifungal Susceptibility Testing.
    Simitsopoulou M; Chatzimoschou A; Roilides E
    Methods Mol Biol; 2016; 1356():183-97. PubMed ID: 26519074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility.
    Zhang X; Sun X; Wang Z; Zhang Y; Hou W
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7774-8. PubMed ID: 23099491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro screening of antifungal compounds able to counteract biofilm development.
    Girardot M; Imbert C
    Methods Mol Biol; 2014; 1147():187-201. PubMed ID: 24664834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
    Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
    Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal Biofilms: Update on Resistance.
    Borghi E; Borgo F; Morace G
    Adv Exp Med Biol; 2016; 931():37-47. PubMed ID: 27115411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal biofilm composition and opportunities in drug discovery.
    Reichhardt C; Stevens DA; Cegelski L
    Future Med Chem; 2016 Aug; 8(12):1455-68. PubMed ID: 27485639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
    Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P
    J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Architecture, influencing factors, and sensitivity to antifungal agents of Candida biofilm].
    Sun QN; Fang K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):385-8. PubMed ID: 12905659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal and anti-biofilm effects of 6-shogaol against Candida auris.
    Kim HR; Eom YB
    J Appl Microbiol; 2021 Apr; 130(4):1142-1153. PubMed ID: 32981148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro growth and analysis of Candida biofilms.
    Chandra J; Mukherjee PK; Ghannoum MA
    Nat Protoc; 2008; 3(12):1909-24. PubMed ID: 19180075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte moulds involved in foot mycosis.
    Toukabri N; Corpologno S; Bougnoux ME; El Euch D; Sadfi-Zouaoui N; Simonetti G
    Mycoses; 2018 Feb; 61(2):79-87. PubMed ID: 28940733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.
    Tetz G; Cynamon M; Hendricks G; Vikina D; Tetz V
    Int J Antimicrob Agents; 2017 Jul; 50(1):47-54. PubMed ID: 28457835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression.
    Khodavandi A; Harmal NS; Alizadeh F; Scully OJ; Sidik SM; Othman F; Sekawi Z; Ng KP; Chong PP
    Phytomedicine; 2011 Dec; 19(1):56-63. PubMed ID: 21924600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms.
    Brilhante RSN; Silva MLQD; Pereira VS; de Oliveira JS; Maciel JM; Silva INGD; Garcia LGS; Guedes GMM; Cordeiro RA; Pereira-Neto WA; de Camargo ZP; Rodrigues AM; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    Med Mycol; 2019 Aug; 57(6):764-772. PubMed ID: 30462271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B.
    Luo J; Wang K; Li GS; Lei DQ; Huang YJ; Li WD; Chen YQ; Kong JL
    Med Sci Monit; 2018 Jan; 24():427-437. PubMed ID: 29356802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strength in numbers: antifungal strategies against fungal biofilms.
    Ramage G; Robertson SN; Williams C
    Int J Antimicrob Agents; 2014 Feb; 43(2):114-20. PubMed ID: 24359842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm characterization of Fusarium solani keratitis isolate: increased resistance to antifungals and UV light.
    Córdova-Alcántara IM; Venegas-Cortés DL; Martínez-Rivera MÁ; Pérez NO; Rodriguez-Tovar AV
    J Microbiol; 2019 Jun; 57(6):485-497. PubMed ID: 31134579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections.
    Muakkassa FK; Ghannoum M
    Adv Exp Med Biol; 2016; 931():95-103. PubMed ID: 27287466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.